Anthem Biosciences Board Meeting for Q1 FY27 Results

Board Meeting Details

A meeting of the Board of Directors is scheduled to be held on Tuesday, July 21, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27).

Trading Window Closure

In continuation of the previous communication dated June 26, 2026, the trading window for dealing in the company's equity shares remains closed. The closure period is from July 1, 2026, until the close of trading hours on July 23, 2026. This represents a closure of 48 hours after the declaration of financial results, implemented in compliance with:

• SEBI (Prohibition of Insider Trading) Regulations, 2015
• The Company's Code of Conduct to regulate, monitor, and report trading by Employees and other Connected persons

Additional Information

The intimation is also available on the Company's website at https://anthembio.com/.

Authentication

The document was digitally signed by Divya Prasad, Company Secretary & Compliance Officer (Membership No: A41438) on July 14, 2026, at 18:43:23 IST.